Watson Biotech announced that the company previously disclosed that it plans to issue shares to specific targets in 2026. On August 27, 2026, it received a notice from the Shenzhen Stock Exchange. The application documents are complete and accepted; the offering still needs to be reviewed by the Shenzhen Stock Exchange and approved for registration by the China Securities Regulatory Commission before it can be implemented.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.